Impact of anti-proliferative drugs and mesh size of active stents on recanalized CTOs at 1 year

Project summary

CONTEXT

Total coronary occlusion (CTO) recanalizations represent a major advance in the field of complex angioplasty. The long-term results of these recanalizations are uncertain and require systematic monitoring after 1 year.

GOALS

To evaluate the impact of different antiproliferative drugs on long-term outcomes of recanalization success.

To evaluate the impact of active stent mesh size on long-term outcomes of recanalized CTOs.

METHODOLOGY

Inclusion of any recanalized CTO without residual stenosis with active stent implantation.